Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.5809
+0.01081.89%
Pre-market: 0.5785-0.0024-0.41%08:59 EDT
Volume:505.32K
Turnover:295.61K
Market Cap:19.33M
PE:-0.62
High:0.6093
Open:0.5768
Low:0.5600
Close:0.5701
52wk High:2.69
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:1.84
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:13.68
PE(LYR):-0.15

Loading ...

Feb 27, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 30, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Major Issues Report

8-K - Current report
Jan 25, 2023

Major Issues Report

8-K - Current report
Jan 24, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Major Issues Report

8-K - Current report
Jan 10, 2023

Major Issues Report

8-K - Current report
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Major Issues Report

8-K - Current report